Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.

MLA

Song, Ruisheng, et al. “Central Role of E3 Ubiquitin Ligase MG53 in Insulin Resistance and Metabolic Disorders.” Nature, vol. 494, no. 7437, Feb. 2013, pp. 375–79. EBSCOhost, https://doi.org/10.1038/nature11834.

APA

Song, R., Peng, W., Zhang, Y., Lv, F., Wu, H.-K., Guo, J., Cao, Y., Pi, Y., Zhang, X., Jin, L., Zhang, M., Jiang, P., Liu, F., Meng, S., Zhang, X., Jiang, P., Cao, C.-M., & Xiao, R.-P. (2013). Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature, 494(7437), 375–379. https://doi.org/10.1038/nature11834

Chicago

Song, Ruisheng, Wei Peng, Yan Zhang, Fengxiang Lv, Hong-Kun Wu, Jiaojiao Guo, Yongxing Cao, et al. 2013. “Central Role of E3 Ubiquitin Ligase MG53 in Insulin Resistance and Metabolic Disorders.” Nature 494 (7437): 375–79. doi:10.1038/nature11834.